(PharmaNewsWire.Com, May 02, 2017 ) Middle-East and Africa Bio pharmaceuticals Market research report, published by Market Data Forecastestimates that the market is growing with a CAGR of 9.16% to reach USD 22.52 billion by 2021, from USD 14.53 billion in 2016.
Bio pharmaceuticals are all those products related to pharmaceutical drugs which are derived or partially synthesized biological sources. It consists of proteins and nucleic acids which are extracted from indirect biological sources for the purpose of therapeutics or vivo diagnostics.
The first biopharmaceutical product which got an approval was Insulin. Biopharmaceuticals can be classified into hematopoietic growth factors, vaccines, interferon, blood factor, monoclonal antibodies, thrombolytic agent and hormone. The extraction of biopharmaceuticals is essential to characterize physiochemical, applying in clinical purposes and for purification. Among the global pharmaceutical market sales, biopharmaceuticals are the estimated to be the fastest growing market which constitutes of about 8% of the market sales.
Key factors which affect and thereby shift the market dynamics are studied intrinsically and are presented in an illustrious way in the report. Some of those factors are Rising disposable income, Increasing demand for healthcare products, Accessible modernised goods and services, Increasing prevalence of obesity, diabetes and heart diseases, Improving healthcare infrastructure in developing markets, Establishment of free zones for foreign countries, Lack of skilled professionals.
For granular level understanding the Bio pharmaceuticals Market is segmented based on product type and therapeutic type, each being provided with Market Size Estimations and Y-o-Y Forecasts.
Based on Product Type: Monoclonal Antibodies (mAb) Erythropoietin Biotech Vaccines Recombinant Human (RH) Insulin Granulocyte colony-stimulating factor (G-CSF) Interferon Human growth hormones (HGH) Based on Therapeutic Type: Neurology Infectious diseases Diabetes Oncology Cardiovascular Other Therapeutic Areas
The Middle-East and Africa market is also analyzed individually in both the regions, thereby providing a more detailed geographical understanding of the market. Some of the major countries that hold significant place in this market include Egypt, KSA, UAE, Nigeria and Algeria.
Some of the key players that operate in the Middle-East and AfricaBio pharmaceuticals market includeAmgen and Genzyme, Pfizer, Merck, Johnson & Johnson, Sanofi-Aventis and Eli Lilly. The Middle-East and AfricaBio pharmaceuticals market report offers wide-range of scope: Regional level analysis that provides an individual perspective of Middle-East and Africa region individually and on a whole Know more about key areas of industry growth via detailedSegment-level analysis on basis of product type and therapeutic type along with market size forecasts and y-o-y estimations Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics Strategic Analyses containingPESTLE and Porters Five Forces Analyseswhich are obtained by studying the macro & micro environmental factors that affect the market demographics Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies Market Outlook - Investment opportunitiesdevised by stand in experts to provide both individuals and organizations a strong financial foothold in the market
For more reports related to the Pharmaceuticals Market:
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: